Varicose Veins Treatment In Bangalore

Bengaluru, India


Ramagondanahalli, Varthur Hobli, Whitefield, 560066, Bengaluru


Columbia Asia is an international healthcare organization operating a chain of more than 12 modern hospitals across Asia. Columbia Asia Hospitals Pvt. Ltd. is one of the first healthcare companies to come to India through 100% Foreign Direct Investment (FDI). Columbia Asia Group is owned by more than 150 private equity companies, fund management organizations and private investors. Columbia Asia hospitals are efficient, hygienic, customer-centric, affordable and accessible. The hospitals’ innovative design, from convenient size to cutting-edge technology, focuses on generating positive experiences for patients. The hospital is the first hospital in India, launched in 2005 in Hebbal, Bangalore. Currently, Columbia Asia operates eleven facilities. The organization has branches in Ahmedabad, Bangalore, Mysore, Kolkata, Gurgaon, Ghaziabad, Patiala and Pune. Columbia Asia Hospitals employs the best professionals from healthcare and other industries, invests in employee training, and has several rewards and recognitions for them. Mission: “To deliver the best clinical outcomes in the most effective, efficient and caring environment” Vision: “Passionate about making people better” The hospitals practice hospitality-based tactics where patients are treated as guests. Their procedures are technology-driven, making them convenient for patients to access their services. All medical programs are supported by a secure trust and the practice of principles, excellence and strict clinical governance. Columbia Asia serves more than one million patients each year. Each hospital offers comprehensive clinical courses supported by numerous ancillary services (ICU, NICU, physical therapy, referral lab, teleradiology/telemedicine, pharmacy and imaging facilities). Columbia Asia Hospitals has been accredited by various medical NABH Accredited Columbia Asia Hospitals in India: – Columbia Asia Hopitals, Hebbal, Bangalore (accredited – 2007, reaccredited 2010 and 2013) – Columbia Asia Referral Hospital, Yeshwanthpur, Bangalore (accredited – 2011, reaccredited 2014) – Columbia Asia Hospital, Palam Vihar, Gurgaon, Haryana (accredited – 2011, reaccredited 2014) – Columbia Asia Hospital, Pune, Maharashtra (accredited – 2014) – Columbia Asia Hospital, Mysore, Karnataka (accredited – 2012, reaccredited 2015) – Columbia Asia Hospital, Patiala, Punjab (accredited – 2014) – Columbia Asia Hospital, Ghaziabad (accredited – 2015) NABL Accredited Columbia Asia Hospitals in India: – Columbia Asia Referral Hospital Yeshwanthpur, Bangalore (accredited – 2010, reaccredited 2012 and 2014) – Columbia Asia Hospital Hebbal, Bangalore (accredited – 2011, reaccredited 2013) – Columbia Asia Hospital Palam Vihar, Gurgaon, Haryana (accredited – 2011, reaccredited 2013 and 2015).


  • Family Accommodation
  • Handicapped accessible
  • Private rooms
  • Parking
  • Open 24 hours
  • Emergency service
  • Wifi access
  • Open weekends
  • Access to public transport
  • Telephone in the room
  • Special dietary

COLUMBIA ASIA WHITEFIELD – Price details/cost breakdown

Physician fee Anesthesia fee Medical team Clinic fee Clinic equipment



All-on-4 dental implants concept Zygomatic dental implants

Best clinics

Obesity and bariatric surgery clinics Cosmetic surgery clinics


Chin surgery/chin correction Removal of eye bags

General Surgery

Magnetic resonance imaging therapies using stem cells


Plastic/surgery – body

Breast implants surgery

Hair restoration

Eyebrow Hair Transplant Facial Hair Transplant Hair Transplant 2000/4000 Hair Transplant 4000 Transplants Body Hair Transplantation


Reproductive Medicine

I.V.F. In vitro fertilization

Cosmetic dentistry

Bariatric surgery

Gastric sleeve – gastrectomy


No treatments available.


Ravindra Puttaswamaiah

Veera Reddy Jayar

Sandhya Balasubramanyan

Lokesh Babu

In addition to the described focal points of my work, various diagnostic options, treatment approaches and therapies are used. In the following you will find a short overview with the most important information. Homeopathy Homeopathy is based on the observation that some substances in a certain concentration can be harmful, pathogenic, or toxic. However, in very low concentrations, so-called potencies, they have the opposite effect – they heal. Naturopathy Naturopathy offers methods and formulas proven over centuries to strengthen specific organ systems and functions of the body. In principle, it is not naturopathy that provides the appropriate remedies, but nature itself. We humans have explored nature and have always used it. Today, naturopathy offers a variety of alternatives and supplements to conventional conventional medicine. What do we mean by naturopathic methods? For example, cupping: Here, a vacuum is created in jars. The glasses are then placed on the skin and suck in the desired areas. This application serves to stimulate the reflex zone on which the cupping head is placed. If the skin is perforated beforehand, the cupping head sucks out blood and relieves the zone to be treated. Or let’s take leeches: Here leeches are placed on mostly inflamed or painful areas. For example, for tennis elbow and meniscus complaints. Since the leeches not only cause local bloodletting by sucking out blood, but also inject hirudin – a substance that inhibits blood clotting – the treated area will continue to bleed for several hours, thus increasing local relief. In addition, anti-inflammatory substances are injected while the leech is sucking. Podiatry soles Podiatry deals with the balance of the feet. Misalignments affect the entire musculoskeletal system of the body and lead to muscle stiffness, joint blockages and fascial adhesions. In my practice, dynamic impressions of your feet are made and the misalignments thus imaged are corrected or balanced by soles measured on you. In this way, statics and posture can be improved from the bottom up. Ear acupuncture You have certainly heard of foot reflexology. Certain areas of the sole of the foot are assigned to organs or organ groups – if these are massaged, this has healing effects on the respective organ. As with the foot, we also find a mirror image of the entire organism in the ear, where we can efficiently stimulate muscles, glands and organs with needles in a very small space. Eye / Iris Diagnosis A diagnostic procedure that is not recognized as scientific today is iris diagnosis. As a “mirror of the soul”, the eye offers deep insights into the processes and structures in the body. Thus, the shape, color and change of the iris can also indicate complaints and malfunctions within the organ systems. Urinalysis In addition to the normal clinical urinalysis, there are many other tests that can be performed on the urine. Among other things, various substances such as alkalis, acids or other solutions can be added. Die Reaktion des Urins gibt je nach entstandener Farbe, Geruch und Konsistenz Aufschluss über Stoffwechselprozesse und Ausscheidungsvorgänge. Ischia, 26.9.2018 | Speakers: Anil Deshpande, Dr. Sandeep Bhagwat, Dr. Meenakshi Pandit, Dr. Varun Naik, Dr. Harish Kumar, Dr. Aarti Prasad

Matrix Health Partner in India – Overview and case studies

Representatives for Matrix Health Partner and Matrix Rhythm Therapy in India who presented on September 26th 2018 case studies on 21 International Matrix Congress in Ischia, Italy From right to left:

  • Aarti Prasad, Physiotherapist, Instructor for MaRhyThe®, Head of Dept. For Physiotherapist, Ramkrishna Super Speciality Hospital, Bangalore
  • Sandeep Bhagwat, Physiotherapist, Instructor for MaRhyThe®, Niramay Rehab Clinic, Solapur
  • Meenakshi Pandit, Physiotherapist, Instructor for MaRhyThe®, Fulcrum Physiotherapy Clinic, Pune
  • Anil Deshpande, Director International Medical Technologies, Official Representative for MaRhyThe India, Mumbai
  • Varun Naik, Physiotherapist, Assistant Professor KAHER Institute for Physiotherapy, Karnataka, Instructor for MaRhyThe®, Consulting Physiotherapist Niramay Physiotherapy Center, Belagavi
  • Harish Kumar, Physiotherapist, Ergonomist, Bookauthor, Sai Health Care Foundation, Mylapore, Chennai

They presented:

  • Overview of MaRhyThe® in India
  • Scientific case studies published
  • Successful treated cases
  • Clinical reports
  • Video-Testimonials from Patients
  • Overview of academic studies in progress

9 years Matrix Rhythm Therapy in India

Dr. Ulrich Randoll officially welcomes Anil Deshpande and his group of practitioners in Ischia and congratulates him on his work and success in the last 9 years for Matrix Rhythm Therapy in India where up to date more than 1000 participants where introduced to Matrix Rhythm Therapy

Anil Deshpande

Anil Deshpande Anil Deshpande, Director International Medical Industries, authorized representative for Matrix Rhythm Therapy India who resides in Mumbai gave an impressive overview of the development in India in the last 9 years as well as figures and facts about India and its colorful diversity and how Matrix Rhythm Therapy is in his opinion great to solve problems of the 21st century due to westernization such as diabetes, stress, heart deseases, hormon imbalances. His vision which is shared by his accompanying instructors and fellow Matrix Health Partners India is to spread the rhythm. Thank you Dr. Randoll for your research on the rhythm of cells and also inventing Matrix Rhythm Therapy for the good health Matrix Rhythm Therapy is the only therapy available to regulate the rhythm of cells, the basic necessity for it’s function

Dr. Sandeep Bhagwat

  • Master of Physiotherapy
  • Director Niramay Rehab Clinic, Solapur
  • Physiotherapist Teacher
  • Matrix Health Partner
  • MaRhyThe® Basic Instructor

He is one of the first physiotherapists in India who decided to integrate Matrix Rhythm Therapy in his physiotherapy clinic. He started with Matrix Rhythm Therapy in 2009, became an instructor for MaRhyThe® in 2014 and has until now over 1000 successful treated cases. Dr. Sandeep Bhagwat’s first case after establishing Matrix Rhythm Therapy in his clinic Niramay Rehab, Solapur, was a non-healing ulcer. Since this successful treated case he have had numerous cases with ulcers and became an expert on ulcer treatments with MaRhyThe® In his presentation at Matrix Congress 2018 in Ischia he showed the audience his 50 most successful cases. It all started with a non-healing ulcer, followed by lots of non-healing ulcers including ulcer at finger tips, frozen shoulder, diabetic foot, improved hand-writing, osteitis, stiff spine, restricted mobilities, pain after molar extractions, traumas, crush injuries, fractures, Parkinson desease, periarthrities, adhesive capsulities, avascular necrosis of femoral head, knee flexion deformity septic arthritis, pedal oedema, Lymphoedeme, radial nerve pulsy and more. Among his patients is also Hrutica, national diving champion and now an ambassador for Matrix Rhythm Therapy, who won the day before 3 gold medals and Tejuswini Sawaut, shooting champion. With Matrix Rhythm Therapy it is now possible to deliver specific frequency at the celluar level to produce a macroscopic change as compared to other modalities till date The Matrix concept, the philosophy is so perfect you can test it with anything for example here Radial Nerve Pulsy. After the Matrix Rhythm Therapy treatment you see a full range of motion, full extension of the arm. Macroscopically visible. You have to believe in the concept, trust, and have to apply your best

Dr. Meenakshi Pandit

  • Chiropractor and Physiotherapist
  • Director of Fulcrum Physiotherapy Clinic in Pune
  • Physiotherapist Teacher
  • Matrix Health Partner
  • MaRhyThe® Basic Instructor

She is Matrix Rhythm Therapist since 2011 and instructor since 2015. In recent years she represents Matrix-Rhythm-Therapy on national and international conferences. In 2016 she won the price as best physiotherapist teacher at Physicon Conference in Srinagar for introducing „Matrix Rhythm Therapy – a non invasive therapy for Pain and Restricted Mobility“. She also holds workshops on Matrix Rhythm Therapy for students at prestigious Dr. D Y Patil College of Physiotherapy in Pune. Among her grateful patients are singer Kriti Shiledar, cricket player Mark Wood and Dr. Swanand Gholap. Dr. Meenakshi Pandit showed at her presentation at International Matrix congress 2018 in Ischia that Matrix Rhythm Therapy works in a way that it regulates the disturbances at all levels. She showed many cases and also gave an insight into her latest studies. Among her grateful patients are singer Kriti Shiledar and cricket player Mark Wood She presented several sucessfull case studies where she showed the audience with pictures how Matrix worked on

  • Scoliosis
  • Venous stasis dermatitits
  • Right upper trapezius trigger
  • Breast cancer
  • Restricted shoulder mobilities
  • Clavicle + PA Shoulder
  • Fractures
  • Shoulder pain
  • Torticolis
  • Hamstring release

Dr. Pandit also started several research studies on Matrix Rhythm Therapy which are in various stages of getting published. One is Brain Mapping Study where she wants to proof that after applying just 5 Minutes of Matrix people get into reset and alpha rhythm. The therapy has combined the whole phenomenon of movements, flow and environment together in such a way that it regulates the disturbances at all the levels. Most of the patients I have treated so far with Matrixmobil they came to me after 1, 2, 3, 4 years of trying everything

Dr. Varun Naik

  • Physiotherapist (KLE Academy of Higher Education & Research)
  • Assistant Professor (KAHER Institute of Physiotherapy, Belagavi, Karnataka
  • Consulting Physiotherapist, Niramay Physiotherapy Center, Belagavi
  • Matrix Health Partner
  • MaRhyThe® Basic Instructor since 2015

Dr. Varun Naik gave in his presentation an overview about all the studies he has brought on the way and which are in various stages of being published. 2015 when he was first introduced to Matrix Rhyhm Therapy all people were asking him was „Is there a study done to proof it?“ – That is one of the reasons why he was interested in staging studies and he assured the audience that the numbers in the studies will indeed attest it. After his presentation about his scientific approach to Matrix Rhythm Therapy and his current patient cases Dr. Varun Naik, Assistant Professor at KAHER Institute of Physiotherapy, answered questions of the expert audience. He encouraged the therapists to do experimental studies because the outcome will be worldwide credited He also showed some of his cases which he presented academically with before-and-after pictures. In the end he showed a video-testimonial of one of his patients – a young woman who got severly insured by an accident where she had numerous fractures and was laying in pain and agony. The work with his patient was going on for a year and now she is able to walk again, can work, and even – something she loves to do – dance. Various studies in progress

  • Migraine
  • Plantar fascitis
  • Low back pain
  • Frozen Shoulder

As I started with Matrix in 2015 everybody did ask me about research papers. Well, I did some research papers and if it is working the numbers will show it Now having done serveral studies, which are in process of being published, I can say: Matrix Rhythm Therapy is working – the numbers show it

Dr. Harish Kumar

  • Physiotherapist and Ergonomist
  • Direktor of Sai Health Care Foundation, Mylapore, Chennai
  • Bookauthor
  • Certified Matrix Rhythm Therapist
  • Matrix Health Partner

Dr. Harish Kumar showed in his presentation at International Matrix Workshop in Ischia successful treated case studies in the last fourteen month since he has established the therapy in his clinic. He thanked the instructors Sandeep, Meenakshi, Aarti and Varun for sharing their profound knowledge. Dr. Harish Kumar, physiotherapist and ergonomist focused in his speech on what has happened in the last fourteen month in his clinic after becoming a certified Matrix Rhythm Therapist. First he emphasized that his spectrum of practise has increased and he is getting more and more testimonials from his patients. He is treating 6 to 7 patients a day, one hour treatment, on a weekly schedule. Then he introduced certain case studies: varicose veins ulcer, venous ulcer, post surgical oedema, torticollis, diabetic neuropathy, lumbago, low back pain, scoliosis and shoulder impingements and other restricted mobilities. The spectrum of practise in my clinic has increased since implementation of Matrix Rhythm Therapy and we have avoided 90 % of surgical procedures In my practise I see 6 to 7 patients a day. We treat them for one hour, on a weekly basis

Dr. Aarti Prasad

  • Physiotherapist
  • Head of Dept. For Physiotherapist, Ramkrishna Super Speciality Hospital, Bangalore
  • Matrix Health Partner
  • MaRhyThe® Basic Instructor

Dr. Aarti Prasad is also one of the first Matrix Rhythm Therapists in India. She started introducing Matrix Rhythm Therapy in Ramkrishna Super Speciality Hospital in 2012 and became an instructor for MaRhyThe® in 2014. Over the years with MaRhyThe® she became an expert in treatment of Frozen Shoulder, Post Traumatic Stiffness and Bell’s Palsy and treats patients with chronic pain and stiffness. But Matrix Rhythm Therapy still amazes her because it is working on cases she would not had thought of to begin with. Dr. Aarti Prasad is also among the first therapists in India who introduced Matrix Rhythm Therapy into Ramkrishna Super Speciality Hospital in Bangalore. In her speech at the 21. International Matrix Congress she showed a case of urinary incontinence and concluded the program by having the audience up from their seats and singing „Omkar“ together. Her latest case is a case of urinary incontinence. The patient, who was seeing quite a few physiotherapists in the US and in India was first treated by her with physiotherapy and exercises. After no results she started with Matrix Rhythm Therapy and with a grateful video statement from her patient, who now walks to the bathroom without dripping, she concluded the speeches from the pracititoners from India. In the very end she brought truly even more spirit of India to the audience. She let the audience get up from their chairs and chanted Omkar with all of them. Namaste! Because of Matrix Rhythm Therapy we get the stars, we get the celebrities, we get the people with pain I think Matrix Rhythm Therapy has become a necessary tool for physiotherapists This page was automatically translated and accurateness of translation is not guaranteed. Please refer to the English version for a source text.

Sicherheit und Wirksamkeit von Trastuzumab als Teil der Behandlung von Brustkrebs

An Indian multicenter, open-label, prospective phase IV study to evaluate the safety and efficacy of trastuzumab in Her2-positive, node-positive, or node-negative high-risk breast cancer as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, with either docetaxel or paclitaxel (AC-TH ) or docetaxel and carboplatin (TCH).

Sponsors Main sponsor: Hoffmann-La Roche
Source Hoffmann-La Roche
Short Abstract This is a prospective, multicenter, single-arm, open-label, interventional phase IV study to evaluate the safety of trastuzumab for the treatment of human epidermal growth factor receptor 2 protein (HER2)-positive node-positive or high-risk node-negative breast cancer participants with a regimen consisting of doxorubicin and cyclophosphamide, followed by either paclitaxel or docetaxel (AC-TH regimen), or a regimen consisting of docetaxel and carboplatin (TCH regimen) in the Indian population.
Overall status Completed
Start date 2015-08-18
Completion Date 2021-06-24
Primary Completion Date 2021-06-24
Phase Phase 4
Study Type Interventional
Primary outcome
Measure Time Frame
Clinically significant changes in cardiac function as determined by measurements of left ventricular ejection fraction (LVEF) by echocardiography Baseline every 4 cycles through cycle 21 (AC-TH), every 4 cycles through cycle 17 (TCH) (each cycle lasting 21 days), at completion of study treatment (12 months after baseline) at 6 months (18 months after baseline), and 12 months follow-up (24 months after baseline)
Percentage of participants with adverse events Baseline to approximately 5 years and 10 months
Secondary outcome
Measure Time window
Disease-free survival (DFS). The date of first study treatment to the date of local, regional, or distant recurrence, contralateral breast cancer, or death from any cause within 12 months of the last trastuzumab dose for each participant
Overall survival (OS) Time from date of first study treatment to date of death, regardless of cause, within 12 months of the last dose of trastuzumab for each participant. Follow-up time was 52 weeks from the last treatment dose in both arms.
Enrollment 110
  • Breast cancer
Intervention Intervention Type:Drug Intervention Name: carboplatin Description: TCH Regimen: carboplatin dose = target area under the curve (AUC) (6 milligrams*milliliter/minute [mg*ml/min]) multiplied by (glomerular filtration rate [GFR] + 25). Carboplatin is administered as an intravenous bolus every 3 weeks for 6 cycles (Cycles 1 through 6). Arm Group Label: trastuzumab Intervention Type: drug Intervention Name: cyclophosphamide Description: AC-TH therapy: cyclophosphamide 600 mg/m^2 i.v. bolus every 3 weeks for 4 cycles (cycles 1 to 4). Arm group label: trastuzumab Intervention type: drug Intervention name: docetaxel Description: AC-TH therapy: docetaxel 100 mg/m^2 IV infusion every 3 weeks for 4 cycles (cycles 5 to 8). TCH treatment: docetaxel 75 mg/m^2 i.v. bolus every 3 weeks for 6 cycles (cycles 1 through 6). Arm group label: trastuzumab Intervention type: drug Intervention name: doxorubicin Description: participants receive doxorubicin 60 mg/m^2 administered as an i.v. bolus injection over 5 to 15 minutes every 3 weeks for 4 cycles for the AC-TH regimen. Arm group label: trastuzumab Intervention type: drug Intervention name: paclitaxel Description: AC-TH treatment: paclitaxel 175 mg/m^2 IV infusion every 3 weeks for 4 cycles (cycles 5 to 8). Arm Group Label: trastuzumab Intervention Type: drug Intervention Name: trastuzumab Description: AC-TH regimen: If administered weekly, 4 milligrams per kilogram (mg/kg) saturation dose on Day 1 of Cycle 5, followed by 2 mg/kg on Day 8 of Cycle 5, and 2 mg/kg every week for 4 cycles ( through Cycle 8). For 3-week dosing, 8 mg/kg saturation dose on Day 1 of Cycle 5, followed by 6 mg/kg every 3 for 4 cycles (through Cycle 8). Beginning on Day 1 of Cycle 9, 6 mg/kg every 3 weeks through Cycle 22 3-week administration, 8 mg/kg saturation dose followed by 6 mg/kg every 3 weeks from Cycles 1 through 6. From Cycle 7, 6 mg/kg every 3 weeks through Cycle 18. All administrations will be intravenous (IV) infusion. Arm label: trastuzumab.
Eligibility Criteria:Inclusion Criteria: – Histologically confirmed early invasive HER2-positive, node-positive, or high-risk node-negative breast cancer with no evidence of residual, locally recurrent, or metastatic breast cancer disease and defined as clinical stage I to IIIA suitable for adjuvant treatment Treatment with Trastuzumab – Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. – HER2 overexpression/amplification, defined as either immunohistochemistry (IHC)3+, or IHC2+ and fluorescence in situ hybridization (FISH) positive, as determined in a central laboratory – Echocardiographically measured LVEF at the time of initiation of trastuzumab therapy – Screening LVEF greater than or equal to (>/=) 55 percent (%) – Adequate bone marrow, Renal and hepatic function – Consent to use of an appropriate non-hormonal contraceptive by women of childbearing potential Exclusion Criteria: – Any contraindication to trastuzumab – Prior adjuvant breast cancer treatment with an approved or investigational anti-HER2 agent – History of other malignancy, excluding curatively treated carcinoma in situ of the cervix or basal cell carcinoma and participants with other curatively treated malignancies who have been disease-free for at least 5 years – History of ductal carcinoma in situ and/or lobular carcinoma, That has been treated with systemic therapy or radiation therapy to the ipsilateral breast where invasive cancer subsequently develops – Locally advanced (stage IIIB and IIIC) and metastatic disease (stage IV) – Clinically relevant cardiovascular disorder or disease – Uncontrolled hypertension or history of hypertensive crisis or hypertensive encephalopathy – History of severe allergic or immunologic reactions, e. g. For example, difficult to control asthma – Pregnant or lactating women Gender: Female Minimum age: 18 years Maximum age: N / A Healthy volunteers: No
Total official
Last name Role Affiliation
Anil Kukreja, MD Study Director Roche Products (India) Pvt. Ltd.
Total Contact Contact information is only displayed if the study is recruiting subjects.
Yashoda Hospital | Hyderabad, Andhra Pradesh, 500082, India
Rajiv Gandhi Cancer Institute & Research Center | New Delhi, Delhi, 110085, India
Manipal Hospital; Department of Oncology | Bangalore, Karnataka, 560017, India
Jehangir Clinical Development Centre Pvt. Ltd; Cancer Research Room | Pune, Maharashtra, 411001, India
MAX Balaji Hospital | Delhi, 110092, India
Dr. GVN Cancer Institute; Medical Oncology | Trichy, 620008, India
Location Countries India
Review date 2022-09-01
Responsible Party Type:Sponsor
Has extended access No
Search condition
  • Breast Neoplasms
Number of arms 1
Arm Group Label:Trastuzumab Type: Experimental Description: Participants will receive trastuzumab as part of an AC-TH or TCH treatment regimen. Regimen choice will be based on the investigator’s discretion with reference to the local trastuzumab prescribing document. AC-TH consists of doxorubicin and cyclophosphamide followed by either paclitaxel or docetaxel. TCH consists of docetaxel and carboplatin. Trastuzumab is common in both treatment regimens and may be administered weekly or every 3 weeks at the investigator’s discretion. Each cycle lasts 3 weeks.
Patient data No
Study Design Info Assignment:N/A Intervention model: single group assignment Main purpose: treatment Masking: none (Open label)

This information was retrieved directly from the website without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on, this will be updated automatically on our website as well.

  • NCT05505175RecruitmentConditions: Breast cancer, Breast cancer
  • NCT05150652RecruitmentConditions: Breast cancer, HER2-negative breast cancer, node-negative breast cancer, breast cancer
  • NCT05584644CompletedConditions: Breast cancer, breast cancer, breast neoplasms, breast tumors, breast cancer
  • NCT04681768RecruitedConditions: Breast cancer/metastatic breast cancer
  • NCT02424682ACompletedConditions: Breast cancer, metastatic breast cancer
  • NCT00983684CompletedConditions: Invasive breast cancer, breast cancer
  • NCT00909441CompletedConditions: Breast cancer, Invasive breast cancer.
  • NCT02111031RecalledConditions: Metastatic breast cancer, Breast cancer.
  • NCT02443467CompletedConditions: Breast cancer, early breast cancer
  • NCT00404066CompletedConditions: Breast cancer, metastatic breast cancer

Carboplatin clinical trials

  • NCT00889018Unknown statusConditions: Intraocular retinoblastoma
  • NCT01654146Unknown StatusConditions: Ovarian cancer
  • NCT00259675CompletedConditions: Non-small cell lung cancer
  • NCT00226915CompletedConditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer.
  • NCT00660842Active, non-recruitingConditions: Ovarian Cancer
  • NCT03652493FinishedConditions: Castration-resistant prostate cancer, metastatic.
  • NCT02734069Unknown StatusConditions: Lung Cancer, sarcopenia, toxicity.
  • NCT01088035FinishedConditions: Ependymoma
  • NCT00098878CompletedConditions: Fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer
  • NCT00145028CompletedConditions: Neoplasms

Varicose Veins Treatment In Bangalore.

Leave a comment

Your email address will not be published. Required fields are marked *